MOREPENLAB — Morepen Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Morepen Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	11,881	15,468	14,175	16,904	18,116
Cost of Revenue
Gross Profit	4,013	4,859	4,472	6,069	6,523
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	10,998	14,378	13,659	15,653	16,665
Operating Profit	882	1,090	516	1,252	1,451
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	985	1,267	558	1,354	1,551
Provision for Income Taxes
Net Income After Taxes	971	1,017	387	966	1,180
Minority Interest
Net Income Before Extraordinary Items
Net Income	971	1,017	387	962	1,180
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	971	1,017	387	962	1,180
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.15	1.96	0.77	1.88	2.2
Dividends per Share